Examination of antibacterial and antifungal activity of selected non-antibiotic products

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 6, 2008, Pages 779-782

  Kruszewska, Hanna ^a   Zarȩba, Tomasz ^a   Tyski, Stefan ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Antimicrobial activity; Candida albicans; Drugs; Escherichia coli; Non antibiotics; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

ACARBOSE; ACICLOVIR; ALITOL; ALLII SATIVAE EXTRACT; ALLOPURINOL; ALLUPOL; ALPRAZOLAM; ANTIINFECTIVE AGENT; APRAZOMERCK; ARGOL; BAZETHAM; BETAMETHASONE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; BETAXOLOL; BETO 200 ZK; BETOPTIC S; BISACODYL; BOBOTIC; BOLDOVERA; CAPTOPRIL; CARTEOLOL; CERATIO; CET ALERGIN; CETIRIZINE; CHOLESTIL; CITABAX; CITALOPRAM; CLOPIDIX; CLOPIDOGREL; DANAZOL; DEBELIZYNA; DELATAR; DEXAK; DOCULAX; DOCUSATE SODIUM; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; E AMINOCAPRONIC ACID; ECOMER; ETORICOXIB; FLUTAMID; FLUTAMIDE; GERONPOL; GINKOFAR VITA; GLIATILIN; GROMELOKSIN; HASCOVIR; HELICID; HEPACOM; HYDROTALCITE; HYMECROMONE; IBEROGEST; IWERMEKTYNA; KORTADDON; LACTULOSE; LACTULOSUM; LOVASTIN; MEFACID; MELOXICAM; MENTOVAL; METAZIDINE; METOHEXAL 200 ZK; METOPROLOL SUCCINATE; MIANSEC; MIOZEPAM; MITRIP; MONONIT 80 RETARD; MYOPAM; NALGESIN; NAPROXEN; NEATIN; PABI ACENOCOUMAROL; PENTOXIFYLLINE; PERINDOPRIL; PHLEBODIA; PLANT EXTRACT; POSORUTIN; PROMETHAZINE; PROXIMETACAINE; PROXYMETACAINE; PULSAREN; QUINAPRIL; RUSCUS ACULEATUS EXTRACT; SALBUTAMOL; SCOPOLAN; SIFOR; SILYMARIN; SIMVACOR; SIMVASTATIN; SIOFOR; SOLIFENACIN; SOREL; STARAZOLIN; SYLICAPS; TACROLIMUS; TAMSUDIL; TANYZ; TEGRETOL CR; TENOX; TERTENSIF SR; TETRYZOLINE; TRIAMCINOLONE; TRIMEBUTINE; TRIMEBUTINE MALEATE; TROXERATIO; ULGASTRAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAGIN; XENTIC; ANTIFUNGAL AGENT;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DRUG SCREENING; DRUG SENSITIVITY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; POLAND;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; POLAND; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 61549098096     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kristiansen J.E.: ASM NEWS 57, 135 (1991).
2. Williams J.D.: J. Antimicrob. Chemother. 35, 721 (1995).
3. Tyski S.: Acta Pol. Pharm. Drug Res. 66, 401 (2003).
4. Guttmann P., Ehrlich, P.: Berliner Klin. Wochenschr. 39, 953 (1891).
5. Hendricks O., Butterworth T.S., Kristiansen JE.: Int. J. Antimicrob. Agents 22, 18 (2003).
6. Molnar J., Ren, J., Kristiansen, J.E.: Antonie van Leeuwenhoek 62, 315 (1992).
7. Kruszewska H., Zarȩba T., Tyski S.: Acta Pol. Pharm. Drug Res. 57 Suppl., 117 (2000).
8. Kruszewska H., Zarȩba T., Tyski S.: Acta Pol. Pharm. Drug Res. 59, 436 (2002).
9. Kruszewska H., Zarȩba T., Tyski S.: Acta Pol. Pharm. Drug Res. 61 Suppl., 436 (2004).
10. Kruszewska H., Zarȩba T., Tyski S.: Acta Pol. Pharm. Drug Res. 63, 457 (2006).
11. Amaral L., Kristiansen J.E., Lorian V.: J. Antimicrob. Chemother. 30, 556 (1992).
12. Chen M., Jensen B., Zhai L., Colding H., Kristiansen J.E.: Int. J. Antimicrob. Agents 19, 195 (2002).
13. Martins M., Dastidar S.G., Fanning S., et al.: Int. J. Antimicrob. Agents 31, 198 (2008).
14. European Pharmacopoeia & 6 ed., (2007).
15. Clonts L.: Microbial Limit and Bioburden Tests: Validation approaches and global requirements, Interpharm Press, Inc., Buffalo Grove (1998).
16. Podlewski J.K., Chwalibogowska & Podlewska A.: Drugs of Contemporary Therapy (in Polish), Split Trading, Warszawa (2004).